unknown
Stage
About
Booster Therapeutics develops small molecule drugs that activate the 20S proteasome to enhance the body's natural protein degradation process, targeting degenerative diseases such as neurodegenerative disorders.
Explore Booster Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.